PulmonarOM (Bacterial Lysates) in Respiratory Tract Infections

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions

Respiratory Tract Infections

Interventions

DRUG

Bacterial Lysates

Bacterial Lysates ampoules 3 mL, oral route, daily for 10 days, followed by 30 days free of medication and then 10 days of administration of the drug

DRUG

placebo

placebo controlled

Trial Locations (1)

Sanofi-Aventis Administrative Office, Col. Coyoacan